I'm reflecting a lot on Aristotle's 3 appeals for effective rhetoric.
In part b/c of the news about the very rare & atypical clots after AstraZeneca & now Janssen J&J vaccination... but also just with how we talk about the science of the pandemic in general.
In response to the news about very rare clots this week (but also during the whole pandemic), we tend to over-emphasize LOGOS in our science communication.
Eg. graphics that only 0.000001% of people who got the JJ vaccine have clots, or comparisons to oral contraceptives.
4/13
Stats are VERY helpful to give context to risk 🙌🏼
There is a really, really small overall risk of these clots. That risk may even be lower for certain demographics, which is part of what these pauses are to help us figure out.
But our scicomm can't stop at the stats.
5/13
Logos is a GOOD starting place... but it can't be the whole story!!
As a young woman who *may* end up being more vulnerable to these clots, who like many others has had health concerns dismissed by docs.... ONLY sharing the stat feels SUPER dismissive to me.
6/13
[Quick note: because this is so rare, there are very few people who have had these atypical clots, which means there's a potential small sample bias here.
We're not entirely sure if it's skewing to more women due to an underlying vulnerability or rollout logistics]
7/13
In any case, the brain operates on more than just logos.
Especially when the limbic system gets involved: we're afraid of a LOT of things that are low risk.
ie. Ever hesitated for a sec to open your eyes in the shower because holy shit there could be a demon !!!!!!
8/13
If stats were enough to calm down a fearful amygdala anxiety wouldn't be a thing 🙃
9/13
Logos may help decelerate anxiety through top-down processing.
So yes it is important to contextualize risk.
But pathos - empathy - is KEY.
Do NOT dismiss or try to trivialize risk. Especially if you're not in the age/gender categories that seem to be more vulnerable.
10/13
The key to this story is relative risk, anyway.
For most, these vaccines remove FAR more risks than they add. These variants are scary AF across ages.
People deserve transparency so they can be empowered to make the decision that is best for them.
11/13
That's where the 3rd appeal comes in.
We *earn* ethos: trustworthiness & credibility.
By being transparent about risks, however small, with logos.
And acknowledging valid fears, especially among those with more reason to distrust healthcare institutions, with pathos.
12/13
To me, good scicomm has LOGOS, PATHOS, and ETHOS.
It packages these into good storytelling and narrative.
And the best scicomm, in my opinion, consistently does this time & time again, building trusting relationships.
That's where we make the most difference long-term.
13/13
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Q: How effective is [the AstraZeneca vaccine] compared to other vaccines?
A: When it comes to just one dose, which is all most people in Canada are gonna have for the next few months, the mRNA vaccines have similar effectiveness to the AstraZeneca.
A friendly reminder to always approach the topic of vaccinations with empathy. Hesitancy is complex & has many layers.
ie. this week, I've been receiving a lot of msgs from people scheduled for 1st or 2nd AstraZeneca vax. They want a vaccine but are SO anxious from the news 😔
Anxiety is also high in those who recently received their 1st dose & are now seeing headlines that have them on edge.
I am glad the potential rare side effect of clots has been so transparently shared by experts & media.
But all the more reason to be kind in our scicomm 💕
I've had anxiety forever (in the midst of finding a new therapist now!🎉), so I feel each one of these messages in my core.
This pandemic really sucks.
I hope through empathetic scicomm with culture + trauma-informed approaches to hesitancy we can end it sooner.
People in their 20s are now disproportionately represented in new COVID-19 cases in Ontario.
Instead of shaming & blaming, I asked them what challenges they’re currently facing with respect to the pandemic.
After 100s of replies, some key themes emerged. Here they are:
Many people in their 20s mentioned peer and social pressure, plus general difficulty navigating behaviours of those around them as a major challenge during the pandemic.
Difficulty seeing or isolating from family was cited as a key challenge folks in their 20s are facing.
This one is big given data from France suggesting cases in young people eventually spread to older folks in 3-5 weeks.
“AEROSOLS” is jargon - IT IS YOUR JOB TO CLEARLY STATE HOW THEY DIFFER FROM DROPLETS WHEN SHARING RESULTS FROM THE NEJM PAPER.
In a nutshell: COVID-19 patients likely cough/sneeze DROPLETS, which are larger than aerosols and all fall to the floor within 1-2m, give or take.
AEROSOLS are smaller so can last in air for longer, but are very likely only produced in hospitals after certain medical procedures
THE TAKEAWAY: this paper does NOT mean SARS-CoV2 is floating around in the air for 3 hrs - it does NOT seem to be airborne like that (the R value would be much higher if it were).
Healthcare workers DO have to deal with aerosols so save the masks for them.